Meloxivet

Withdrawn

This medicine's authorisation has been withdrawn

meloxicam

Overview

The marketing authorisation for Meloxivet has been withdrawn at the request of the marketing authorisation holder.

Meloxivet : EPAR - Summary for the public

Product information

Meloxivet : EPAR - Product Information

Latest procedure affecting product information: IG/0437

28/05/2014

Meloxivet : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Meloxivet
• Active substance:
  meloxicam
• International non-proprietary name (INN) or common name:
  meloxicam
• Species:
  Dogs
• Anatomical therapeutic chemical veterinary (ATCvet) code:
  QM01AC06

Pharmacotherapeutic group

Musculo-skeletal system

Therapeutic indication

Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.

Authorisation details

• EMA product number:
  EMEA/V/C/000124
• Generic:

  This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

• Marketing authorisation holder:
  Eli Lilly and Company Limited

  Eli Lilly and Company Limited; Elanco Animal Health,; Lilly House; Priestley Road; Basingstoke; RG24 9NL; United Kingdom

• Marketing authorisation issued:
  14/11/2007
• Revision:
  5

Assessment history

Changes since initial authorisation of medicine

Meloxivet : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Meloxivet : EPAR - Scientific Discussion

Meloxivet : EPAR - Procedural steps taken before authorisation